Brain Awake Surgery Using Virtual Reality Headset

Feasibility and tolerance study of virtual reality headset for brain mapping during brain awake surgery.

Completed

Looking for future studies?

Key information

Conditions

Brain Tumor Brain Diseases Brain Neoplasms Central Nervous System Diseases Central Nervous System Neoplasms Glioma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Neuroepithelial Nervous System Diseases Nervous System Neoplasms Neuroectodermal Tumors Virtual Reality

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Angers

Angers, 49000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Unilateral tumor or any type of brain lesion localized at the vicinity of eloquent area

Exclusion criteria

Emergency
Any contra-indication to awake brain surgery

Treatment and study plan

Virtual Reality Headset

Device

Feasibility and tolerance

Other names: awake craniotomy

Primary outcomes

percentage of patients in which assessment of language functions during awake craniotomy, is possible with virtual reality headset.

Time frame: During awake surgery

Sponsors and collaborators

Lead sponsor

University Hospital, Angers

Other Gov

Registry information

Official study title

Chirurgie Eveillee du Cerveau Sous Realite Virtuelle Integree Aux Outils Bloc Operatoire : Etude de Tolerance

Acronym: CERVO1

Important dates

Study start: 2017
Primary completion: 2020
Study completion: 2020
First posted: Jan 5, 2017
Registry last updated: Apr 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed